SCHEMBL8950502

SCHEMBL8950502

CC(C)n1ncnc1-c1ccncc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
PIK3CA P42336 7/20 0.37
PDE2A O00408 1/20 0.36
PDE10A Q9Y233 1/20 0.36
DGAT1 O75907 1/20 0.35
LIMK1 P53667 1/20 0.35
NFATC1 O95644 1/20 0.35
GSK3B P49841 1/20 0.35
DYRK1A Q13627 1/20 0.35
CDC25B P30305 1/20 0.34
PIK3CD O00329 3/20 0.33
PIK3CB P42338 3/20 0.33
PIK3CG P48736 3/20 0.33
CYP17A1 P05093 2/20 0.33
CYP1A2 P05177 1/20 0.33
GAA P10253 1/20 0.33
KCNH2 Q12809 1/20 0.33
AOC3 Q16853 1/20 0.33
ABL1 P00519 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8950307 0.82 ADRA1D (0.41) ADRA1DADRA1APIK3CAPIK3CDPIK3CB
SCHEMBL8994827 0.80 BDKRB2 (0.43) ADRA1DADRA1APDE2APDE10ANFATC1
SCHEMBL8950122 0.74 TDP1 (0.42) ADRA1DADRA1APIK3CADGAT1NFATC1
SCHEMBL8950388 0.72 PIK3CA (0.41) ADRA1DADRA1APIK3CAGSK3BPIK3CD
SCHEMBL8950449 0.72 PIK3CD (0.48) PIK3CAPIK3CDPIK3CBPIK3CGCYP1A2
SCHEMBL8950095 0.71 PIK3CA (0.38) ADRA1DADRA1APIK3CACYP1A2
SCHEMBL31301252 0.68 GSK3B (0.59) LIMK1NFATC1GSK3BDYRK1ACDC25B
SCHEMBL8950490 0.67 ADRA1D (0.36) ADRA1DADRA1APIK3CADGAT1DYRK1A
SCHEMBL24185681 0.66 DGAT1 (0.41) ADRA1DADRA1APIK3CADGAT1PIK3CD
SCHEMBL8950312 0.65 PIK3CA (0.43) ADRA1DADRA1APIK3CADGAT1LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188085-B2 Antifungal agents MERCK SHARP & DOHME CORP. (US) 2012-05-29 US disclosed
US-20100113439-A1 Antifungal agents MERCK & CO., INC. (US) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113439-A1 Antifungal agents GMDS, GBA3, UGGT1 ADRA1D 2746/4885ADRA1A 3372/4885PIK3CA 881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.